IntraOp Medical Corporation, headquartered in the United States, is a pioneering force in the medical technology industry, specialising in innovative intraoperative radiation therapy (IORT) solutions. Founded in 2005, the company has made significant strides in enhancing cancer treatment through its flagship product, the Mobetron, which delivers targeted radiation directly to tumours during surgery, minimising damage to surrounding healthy tissue. With a strong presence in North America and expanding operations in Europe, IntraOp Medical has established itself as a leader in the field of cancer care. The company's commitment to advancing surgical oncology has garnered recognition, positioning it at the forefront of IORT technology. By integrating cutting-edge engineering with clinical expertise, IntraOp continues to redefine standards in patient care and improve outcomes for cancer patients worldwide.
How does IntraOp Medical Corporation's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Mean score of companies in the Business Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
IntraOp Medical Corporation's score of 23 is lower than 67% of the industry. This can give you a sense of how well the company is doing compared to its peers.
IntraOp Medical Corporation, headquartered in the US, currently does not report any carbon emissions data, as indicated by the absence of specific figures in kg CO2e. Additionally, there are no documented reduction targets or climate pledges associated with the company. This lack of data suggests that IntraOp may not have established formal commitments to reduce its carbon footprint or engage in industry-standard climate initiatives. As a result, IntraOp Medical Corporation's climate commitments remain unclear, and the company does not appear to inherit any emissions data or targets from a parent organisation. Without specific emissions figures or reduction initiatives, it is challenging to assess their environmental impact or commitment to sustainability within the medical technology sector.
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
IntraOp Medical Corporation is not participating in any of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.